RecruitingNot ApplicableNCT06330870

Brain Metastasis Development Mechanism in BCBM Patients

Evaluation of Brain Metastasis Development Mechanism in Patients With Breast Cancer With Brain Metastasis(BCBM)


Sponsor

Samsung Medical Center

Enrollment

30 participants

Start Date

Apr 6, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study is the experimental study for brain metastasis development mechanism in patients with breast cancer with brain metastasis


Eligibility

Sex: FEMALE

Plain Language Summary

Simplified for easier understanding

This study is investigating how breast cancer spreads to the brain — a serious complication called brain metastasis — by analyzing tissue samples from patients who have had brain surgery to remove these tumors. Understanding the biology of how breast cancer cells travel to and grow in the brain may help scientists develop better treatments to prevent or treat this condition. **You may be eligible if:** - You have been diagnosed with breast cancer - You are undergoing or have undergone open surgery to remove a brain metastasis (a tumor that has spread from breast cancer to the brain) **You may NOT be eligible if:** - Your brain metastasis was treated with Gamma Knife radiosurgery (a non-surgical radiation treatment) instead of open surgery Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREWGS/TME evaluation

WGS/TME evaluation with blood and brain metastasis tissue during brain metastasis curative surgery


Locations(1)

Ji-Yeon Kim

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06330870


Related Trials